|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Clinical Studies Section, Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute (Dr. Brantly), the Warren G. Magnuson Clinical Center, Diagnostic Radiology Department (Dr. Avila), and the Section on Human Biochemical Genetics, Heritable Disorders Branch (Drs. Shotelersuk, Huizing, and Gahl, and Ms. Lucero), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Correspondence to: William A. Gahl, MD, PhD, 10 Center Dr, MSC 1830, Building 10, Room 9S-241, NICHD, NIH, Bethesda, MD 20892-1830; e-mail: bgahl{at}helix.nih.gov
Objective: To describe and correlate pulmonary function and high-resolution CT (HRCT) scan scores in individuals with a high risk for development of pulmonary fibrosis, ie, Hermansky-Pudlak syndrome (HPS) patients with mutations in the HPS-1 gene.
Design: Cross-sectional analysis of consecutive, eligible patients.
Patients: Thirty-eight HPS inpatients at the National Institutes of Health Clinical Center with HPS-1 mutations.
Results: Thirty-seven patients were Puerto Rican and
exhibited the typical 16-base pair (bp) duplication in exon 15 of
HPS-1. One non-Puerto Rican was homozygous for a different
mutation (intervening sequence 17 -2 A
C) previously reported in the
HPS-1 gene; he died at age 35 of pulmonary insufficiency.
For the 23 patients who had pulmonary symptoms, the mean age of onset
was 35 years. For all 38 patients (mean age, 37 ± 2 years), the mean
FVC was 71% of predicted; the mean FEV1, 76%; mean total
lung capacity (TLC), 72%; mean vital capacity (VC), 68%; and mean
diffusing capacity of the lung for carbon monoxide (DLCO),
72%. When patients were grouped according to the extent of their
reduction in FVC, the other four pulmonary function parameters followed
the FVC. Seventeen patients had abnormal chest radiographs, and 31
(82%) had abnormal HRCT scans of the chest, for which a scoring system
of 0 (normal) to 3 (severe fibrosis) is presented. The mean ± SEM
HRCT score for 38 patients was 1.30 ± 0.17. HRCT scores correlated
inversely with FVC and DLCO.
Conclusions: Mutations in the HPS-1 gene, whether or not they involve the typical 16-bp duplication seen in Puerto Rican patients, are associated with fatal pulmonary fibrosis. In affected patients, the FVC, FEV1, TLC, VC, and DLCO fall in concert, and this functional deficit correlates with HRCT scan evidence of progression of interstitial lung disease.
Key Words: albinism CT scans pulmonary fibrosis pulmonary function tests
This article has been cited by other articles:
![]() |
F. J. Martinez and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Guttentag, A. Akhtar, J.-Q. Tao, E. Atochina, M. E. Rusiniak, R. T. Swank, and S. R. Bates Defective Surfactant Secretion in a Mouse Model of Hermansky-Pudlak Syndrome Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 14 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Poddar, S. Coley, and S. Pavord Hermansky-Pudlak syndrome in a pregnant patient Br. J. Anaesth., November 1, 2004; 93(5): 740 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Avila, M. Brantly, A. Premkumar, M. Huizing, A. Dwyer, and W. A. Gahl Hermansky-Pudlak Syndrome: Radiography and CT of the Chest Compared with Pulmonary Function Tests and Genetic Studies Am. J. Roentgenol., October 1, 2002; 179(4): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gwynn, S. L. Ciciotte, S. J. Hunter, L. L. Washburn, R. S. Smith, S. G. Andersen, R. T. Swank, E. C. Dell'Angelica, J. S. Bonifacino, E. M. Eicher, et al. Defects in the cappuccino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky-Pudlak syndrome by an AP-3-independent mechanism Blood, December 15, 2000; 96(13): 4227 - 4235. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |